WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators of colorectal cancer incidence compared with BMI, according to a study ...

As BMI is increasingly recognized as an imperfect way to measure health, UVA researchers share other metrics they rely upon.

Objective To investigate the correlation between caregivers’ health-related behaviours and the prevalence of ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company ...

They don't represent what's typical or healthy for everybody There are so many factors that make ... weight and reducing the ...

Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...

A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...

A new report published Monday found that heart disease continues to be the leading cause of death in the United States.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Several conditions, including high blood pressure, high blood cholesterol, diabetes, overweight and obesity ... the risk of serious heart disease, regardless of other risk factors.